
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Resveratrol and temozolomide induce apoptosis and suppress proliferation in glioblastoma cells via the apoptotic signaling pathway - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7134E89B72EF31C134E0028110BC7.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="actchirbras">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333572/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Acta Cirúrgica Brasileira">
<meta name="citation_title" content="Resveratrol and temozolomide induce apoptosis and suppress proliferation in glioblastoma cells via the apoptotic signaling pathway">
<meta name="citation_author" content="Görkem Tutal Gürsoy">
<meta name="citation_author_institution" content="Ankara City Hospital - Department of Neurology - Ankara - Turkey.">
<meta name="citation_author" content="Mehmet Cudi Tuncer">
<meta name="citation_author_institution" content="Dicle University - Faculty of Medicine - Department of Anatomy - Diyarbakir - Turkey.">
<meta name="citation_author" content="İlhan Özdemir">
<meta name="citation_author_institution" content="Atatürk University - Faculty of Medicine - Department of Gynecology and Obstetrics - Erzurum - Turkey.">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="40">
<meta name="citation_firstpage" content="e405525">
<meta name="citation_doi" content="10.1590/acb405525">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333572/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333572/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333572/pdf/1678-2674-acb-40-e405525.pdf">
<meta name="description" content="Glioblastoma (GBM) is the most common primary brain tumor in the central nervous system. Studies revealing the molecular mechanisms regulating GBM pathogenesis are currently limited. This study aimed to investigate the expression of genes ...">
<meta name="og:title" content="Resveratrol and temozolomide induce apoptosis and suppress proliferation in glioblastoma cells via the apoptotic signaling pathway">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Glioblastoma (GBM) is the most common primary brain tumor in the central nervous system. Studies revealing the molecular mechanisms regulating GBM pathogenesis are currently limited. This study aimed to investigate the expression of genes ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333572/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12333572">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1590/acb405525"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/1678-2674-acb-40-e405525.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333572%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12333572/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12333572/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333572/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-actchirbras.jpg" alt="Acta Cirúrgica Brasileira logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Acta Cirúrgica Brasileira" title="Link to Acta Cirúrgica Brasileira" shape="default" href="http://www.scielo.br/acb" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Acta Cir Bras</button></div>. 2025 Aug 8;40:e405525. doi: <a href="https://doi.org/10.1590/acb405525" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1590/acb405525</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Acta%20Cir%20Bras%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Acta%20Cir%20Bras%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Acta%20Cir%20Bras%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Acta%20Cir%20Bras%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Resveratrol and temozolomide induce apoptosis and suppress proliferation in glioblastoma cells via the apoptotic signaling pathway</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22G%C3%BCrsoy%20GT%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Görkem Tutal Gürsoy</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Görkem Tutal Gürsoy</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>1</sup>Ankara City Hospital - Department of Neurology - Ankara - Turkey.</div>
<div>Conception and design, Acquisition of data, Analysis and interpretation of data, Technical procedures, Manuscript preparation, Manuscript writing, Critical revision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22G%C3%BCrsoy%20GT%22%5BAuthor%5D" class="usa-link"><span class="name western">Görkem Tutal Gürsoy</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tuncer%20MC%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mehmet Cudi Tuncer</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Mehmet Cudi Tuncer</span>, <span class="degrees">PhDs</span>
</h3>
<div class="p">
<sup>2</sup>Dicle University - Faculty of Medicine - Department of Anatomy - Diyarbakir - Turkey.</div>
<div>Conception and design, Acquisition of data, Analysis and interpretation of data, Technical procedures, Manuscript preparation, Manuscript writing, Critical revision, Final approval of version to be published</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tuncer%20MC%22%5BAuthor%5D" class="usa-link"><span class="name western">Mehmet Cudi Tuncer</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22%C3%96zdemir%20%C4%B0%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">İlhan Özdemir</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">İlhan Özdemir</span>, <span class="degrees">PhDs</span>
</h3>
<div class="p">
<sup>3</sup>Atatürk University - Faculty of Medicine - Department of Gynecology and Obstetrics - Erzurum - Turkey.</div>
<div>Conception and design, Acquisition of data, Analysis and interpretation of data, Technical procedures, Manuscript preparation, Manuscript writing, Critical revision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22%C3%96zdemir%20%C4%B0%22%5BAuthor%5D" class="usa-link"><span class="name western">İlhan Özdemir</span></a>
</div>
</div>
<sup>3</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff01">
<sup>1</sup>Ankara City Hospital - Department of Neurology - Ankara - Turkey.</div>
<div id="aff02">
<sup>2</sup>Dicle University - Faculty of Medicine - Department of Anatomy - Diyarbakir - Turkey.</div>
<div id="aff03">
<sup>3</sup>Atatürk University - Faculty of Medicine - Department of Gynecology and Obstetrics - Erzurum - Turkey.</div>
<div class="author-notes p">
<div class="fn" id="c01">
<sup>*</sup><p class="display-inline">
 Corresponding author: <span>drcudi@hotmail.com</span>
</p>
</div>
<div class="fn" id="fn1"><p><strong>Section editor:</strong> Eberval Gadelha <a href="https://orcid.org/0000-0001-7754-4178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0001-7754-4178</a>
</p></div>
<div class="fn" id="fn2"><p><strong>Conflict of interest:</strong> Nothing to declare.</p></div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Görkem Tutal Gürsoy</span></strong>: <span class="degrees">MD</span>, <span class="role">Conception and design, Acquisition of data, Analysis and interpretation of data, Technical procedures, Manuscript preparation, Manuscript writing, Critical revision</span>
</div>
<div>
<strong class="contrib"><span class="name western">Mehmet Cudi Tuncer</span></strong>: <span class="degrees">PhDs</span>, <span class="role">Conception and design, Acquisition of data, Analysis and interpretation of data, Technical procedures, Manuscript preparation, Manuscript writing, Critical revision, Final approval of version to be published</span>
</div>
<div>
<strong class="contrib"><span class="name western">İlhan Özdemir</span></strong>: <span class="degrees">PhDs</span>, <span class="role">Conception and design, Acquisition of data, Analysis and interpretation of data, Technical procedures, Manuscript preparation, Manuscript writing, Critical revision</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 11; Accepted 2025 May 22; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12333572</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="sec1"><h3 class="pmc_sec_title">Purpose:</h3>
<p>Glioblastoma (GBM) is the most common primary brain tumor in the central nervous system. Studies revealing the molecular mechanisms regulating GBM pathogenesis are currently limited. This study aimed to investigate the expression of genes responsible for the apoptotic pathway (p21, p27, p53) after separate and combined application of the natural components resveratrol (Res) and temozolomide (TMZ) in the GBM cell line (U118).</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods:</h3>
<p>In this study, the GBM cell line U118 was used. Apoptotic activation of Res and TMZ via the p21, p27, p53 signaling pathway was evaluated by quantitative reverse transcription polymerase chain reaction and TaLi cytometry. Cell viability was also assessed using the MTT assay.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results:</h3>
<p>Res and TMZ inhibited the proliferation and migration of U118 cells. Additionally, Res induced apoptosis by arresting the cell cycle. Moreover, Res treatment upregulated the expression of p27 and p53, which are associated with apoptosis, while it significantly downregulated the expression of the p21 gene.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion:</h3>
<p>These results indicated that Res and TMZ suppressed the proliferation of GBM cells through apoptotic pathways. Together, Res and TMZ may represent a promising combination for suppressing tumors through apoptotic mechanisms.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Key words:</strong> Resveratrol, Temozolomide, Apoptosis, Glioblastoma, Cell Survival</p></section></section><section id="sec5"><h2 class="pmc_sec_title">Introduction</h2>
<p>Glioblastoma (GBM) is the most common primary brain tumor in the central nervous system, accounting for approximately 45-50% of all gliomas. Despite modern diagnostic and therapeutic approaches such as surgical resection, radiation, and chemotherapy, patients have an average survival of 12 to 15 months. However, after surgical removal of tumor tissue, tumor recurrence often occurs within 1 cm of the resection cavity. This is mostly related to migration of cells from tumor tissue to normal brain tissue during surgery<a href="#B01" class="usa-link" aria-describedby="B01">1</a>.</p>
<p>GBMs have been classified into four stages by the World Health Organization (WHO), based on histological, prognostic, and survival characteristics. Stage IV glioma, the most malignant class of GBM, is characterized by an extremely poor prognosis, with an average survival rate of only 3.3% at two years and 1.2% at three years. On the other hand, it has been reported that some low-grade gliomas may also progress to GBM. These are called secondary glioblastomas, while de novo GBM tumors are called primary glioblastomas<a href="#B02" class="usa-link" aria-describedby="B02">2</a>.</p>
<p>GBM formation is a complex, multistep process that includes cellular neoplastic transformation, resistance to apoptosis, loss of control of the cell cycle, angiogenesis, and acquisition of invasive properties. Nuclear factor-kappa B (NF-κB), reactive oxygen and nitrogen species, and specific microRNAs are key mediators of cancer progression. These mediators create a pro-tumorigenic response through changes in cell proliferation, cell lifespan, cellular senescence, DNA mutation rates, DNA methylation, and angiogenesis<a href="#B03" class="usa-link" aria-describedby="B03">3</a>.</p>
<p>Alkylating agents are the most used chemotherapeutic drugs in the treatment of GBM. GBM is classified as a WHO grade IV astrocytic tumor and represents the most aggressive form of primary brain malignancy. According to the 2021 WHO classification of central nervous system tumors, GBM is typically isocitrate dehydrogenase (IDH)-wildtype and exhibits features such as necrosis and/or microvascular proliferation. While some lower-grade gliomas (WHO grades II and III) may undergo malignant transformation into secondary glioblastomas, primary glioblastomas arise de novo and are classified as grade IV from the outset.</p>
<p>This updated classification emphasizes molecular profiling, such as IDH mutation status, to better define tumor subtypes and prognostic expectations<a href="#B04" class="usa-link" aria-describedby="B04">4</a>. It causes damage by adding a methyl group to the O6 position of guanine in the most critical region of DNA. This damage causes cancer cells to stop in the G2/M cell cycle and leads to apoptosis<a href="#B05" class="usa-link" aria-describedby="B05">5</a>. Temozolomide (TMZ) is frequently used in the treatment of recurrent glioma and has an antitumor effect. Treatment with TMZ causes O-6-methylguanine-DNA methyltransferase upregulation and increases cancer resistance. Therefore, while TMZ is used as a chemotherapeutic drug, it also paves the way for tumor recurrence<a href="#B06" class="usa-link" aria-describedby="B06">6</a>,<a href="#B07" class="usa-link" aria-describedby="B07">7</a>. Malignant gliomas are usually treated with TMZ, but tumor cells are resistant to this chemotherapy.</p>
<p>Nowadays, interest in resveratrol (Res) has increased greatly. It is known that Res has antioxidant and anti-inflammatory effects that play a role in the basis of many diseases. Its potential importance in the prophylaxis/treatment of chronic diseases such as cancer, heart diseases, diabetes, obesity, and aging-related eye diseases has been proven <em>in vitro</em> and <em>in vivo</em>
<a href="#B08" class="usa-link" aria-describedby="B08">8</a>. It is known that Res inhibits cellular events related to the three main steps of carcinogenesis-initiation, proliferation and metastasis-by inducing cell cycle arrest and apoptosis-mediated cell death. Its growth inhibitory effect on various cancer cells has been demonstrated in vitro. These include colon, prostate, breast, lymphoma and leukemia, cancer cells<a href="#B09" class="usa-link" aria-describedby="B09">9</a>,<a href="#B10" class="usa-link" aria-describedby="B10">10</a>. It has been reported that Res suppresses antitumor by strengthening the immune system<a href="#B11" class="usa-link" aria-describedby="B11">11</a>. In a cancer study, it has been reported that the Res analog HS-1793 enhances the function of radiotherapy by strengthening immunity in breast cancer<a href="#B12" class="usa-link" aria-describedby="B12">12</a>. However, the combined effect of Res with chemotherapy agents is very limited.</p>
<p>In this study, the anticancer activity of Res was investigated with TMZ, which is frequently used in the treatment of GBM.</p></section><section id="sec6"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec7"><h3 class="pmc_sec_title">Experimental workflow</h3>
<p>The study followed a systematic experimental workflow. U118 GBM cells were cultured under controlled conditions and treated with Res and TMZ at varying concentrations. Cell viability was assessed using the MTT assay to determine cytotoxic effects. Apoptotic activity was evaluated through Tali cytometry, while gene expression changes in apoptotic markers (p21, p27, p53) were analyzed using quantitative reverse transcription polymerase chain reaction (RT-qPCR). Protein-protein interactions were examined via the STRING database, followed by functional enrichment analysis using GO and KEGG pathway tools. Finally, statistical analyses were conducted to validate the findings and interpret the biological significance of the results (<a href="#f01" class="usa-link">Fig. 1</a>).</p>
<figure class="fig xbox font-sm" id="f01"><h4 class="obj_head">Figure 1. Res and TMZ experimental workflow in glioblastoma research. Res: resveratrol; TMZ: temozolomide; RT-qPCR: quantitative reverse transcription polymerase chain reaction.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333572_1678-2674-acb-40-e405525-gf01.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30d/12333572/9734372a0231/1678-2674-acb-40-e405525-gf01.jpg" loading="lazy" height="1666" width="771" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f01/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Source: Elaborated by the authors.</p></figcaption></figure></section><section id="sec8"><h3 class="pmc_sec_title">Agents</h3>
<p>Res was dissolved in dimethyl sulfoxide (DMSO; SigmaChem Co., St. Louis, United States of America) to prepare a stock solution at concentration of 100 mM, and TMZ (3,4-dihydro-3-methyl-4-oxoimidazo [5,1-d]-as-tetrazine-8-carboxamide) (SigmaChem Co., St. Louis, United States of America) was dissolved in DMSO to prepare a stock solution at concentration of 1 mM for protection against light and stored at -20°C. MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) was purchased from Sigma (SigmaChem Co., St. Louis, United States of America).</p></section><section id="sec9"><h3 class="pmc_sec_title">Cell culture</h3>
<p>The human U118 GBM cell line was used in the study. It was cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS), 3.5 mg/mL glucose, and 1% penicillin/streptomycin at 37°C temperature, 95% humidity and 5% CO<sub>2</sub>. The culture medium was changed every 24 hours until the cells reached the required majority. For the experiments, cells were treated with different concentrations of TMZ (5, 10, 25, 50, 75, 100, 250 and 500 μM) and Res (5, 10, 25, 50, 75, 100, 250, 500) for 24 and 48 h.</p></section><section id="sec10"><h3 class="pmc_sec_title">Cell viability</h3>
<p>MTT test was performed for cell survival (viability) analysis after incubation. For this purpose, the “Yellow tetrazolium MTT” test solution, prepared at the dose of 5 mg/mL, was pipetted into all wells at 20 µL/well. Then, the plates were left to incubate for 4 h. After the incubation, the medium in the wells was completely removed, and 200 µL ultra-puree DMSO (Merk, United States of America) was added to each well and waited in the incubator under dark conditions for 2-4 h. At the end of this period, the plates were read spectrophotometrically at 490 nm wavelengths with a Multiskan GO microplate reader (ThermoScientific, United States of America). The value obtained from the vehicle-treated control group was determined as a comparative viability rate based on 100% viability.</p></section><section id="sec11"><h3 class="pmc_sec_title">Apoptotic assay</h3>
<p>Apoptosis determination studies with Tali cytometer were performed according to the kit procedure using Tali Apoptosis Kit-Annexin V AlexaFluor 488 and PropidiumIodide (Life technologies). For the apoptosis determination study with the Tali cytometer, cells were planted in a 24-well plate with 1 mL of medium at approximately 5 × 104 cells/well. Depending on the proliferation status of the cells, they were incubated in a carbon dioxide incubator for one or two days. Application was made with the application doses determined in the previous study. At the end of the 48-h incubation period, the medium in the 24-well plates was removed. One-mL trypsin ethylenediamine tetraacetic acid (EDTA) was added to these wells, incubated for 10 minutes, and the cells were collected with an automatic pipette and placed in Eppendorf tubes. They were centrifuged at 700 rpm for 2 minutes. At the end of the centrifugation process, the upper trypsin and supernatant were completely removed, and the cells that settled at the bottom of the tube were used for analysis. After incubation, 25 µL of the mixture in the tubes was poured onto special slides prepared for Tali and read with the Tali apoptosis analysis program.</p></section><section id="sec12"><h3 class="pmc_sec_title">Combination index calculation and synergism evaluation</h3>
<p>To determine the nature of the interaction between Res and TMZ, combination index (CI) analysis was performed based on the Chou-Talalay method. U118 GBM cells were treated with Res, TMZ, and a fixed-ratio combination of both agents across a range of concentrations for 48 h. Cell viability was determined via MTT assay, and percentage inhibition was calculated. Interpolated dose-response curves for single agents were used to estimate the equivalent doses (Dx) needed to achieve the same effect as the combination doses. CI values were calculated using <a href="#e01" class="usa-link">Eq. 1</a>:</p>
<table class="disp-formula p" id="e01"><tr>
<td class="formula"><math id="e011" display="block" overflow="linebreak"><mi>C</mi><mi>I</mi><mo> </mo><mo>=</mo><mo> </mo><mo>(</mo><mi>D</mi><mn>1</mn><mo>/</mo><mi>D</mi><msub><mi>x</mi><mn>1</mn></msub><mo>)</mo><mo> </mo><mo>+</mo><mo> </mo><mo>(</mo><mi>D</mi><mn>2</mn><mo>/</mo><mi>D</mi><msub><mi>x</mi><mn>2</mn></msub><mo>)</mo></math></td>
<td class="label">(1)</td>
</tr></table>
<p>where: D<sub>1</sub> is the dose of Res used in combination treatment to achieve a specific percentage of cell inhibition in GBM U118 cells; D<sub>2</sub> is the dose of TMZ used in combination treatment to achieve the same level of inhibition as D1; Dx<sub>1</sub> is the dose of Res required to produce the same percentage of inhibition when used alone; Dx<sub>2</sub> is the dose of TMZ required to produce the same percentage of inhibition when used alone.</p>
<p>D<sub>1</sub> and D<sub>2</sub> are the doses in combination, and Dx<sub>1</sub> and Dx<sub>2</sub> are the doses of each agent alone. CI &lt; 1 indicates synergy, CI = 1 indicates an additive effect, and CI &gt; 1 indicates antagonism. The results were visualized as a dose-CI curve and tabulated with interpretative categories.</p></section><section id="sec13"><h3 class="pmc_sec_title">Quantitative reverse transcription polymerase chain reaction analysis</h3>
<p>During the isolation phase, Purelink RNA mini kit (Thermo, United States of America) was used, and the kit protocol was followed. RNA samples (High-capacity cDNA reverse transcription kit, Applied Biosystem) were converted into cDNA according to the kit procedure. cDNA amounts were determined with Take3 Plate (Epoch Spectrophotometer System, Biotek). P21, p27 and p53 expression analysis were performed. Quantitative PCR analysis was performed with TaqMan probe mixed solution (Taqman Probe-based technology, Applied Biosystem). The Βeta actin gene was used as an endogenous control. Optical PCR plates were used for RT-qPCR analysis, and each group was studied in three replicates. Results were calculated with the 2-ΔΔCt method15 and are presented as fold change compared to the control group. In the study, the expression levels of P21, p27 and p53 pathway genes in control and treatment groups of GBM cells were analyzed by RT-qPCR method. The primers used to investigate the changes in the expression of these genes are given in <a href="#t01" class="usa-link">Table 1</a>, in 5’-3’ order.</p>
<section class="tw xbox font-sm" id="t01"><h4 class="obj_head">Table 1. Primer sequences used for quantitative reverse transcription polymerase chain reaction analysis of target genes.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="rows"><tbody>
<tr style="border-top-color:#F68B3D"><td rowspan="1" colspan="1"> P21<sup>Chip1</sup>: F: GGCGTTTGGAGTGGTAGAAA, R: GACTCTCAGGGTCGAAAACG</td></tr>
<tr><td rowspan="1" colspan="1"> P27<sup>Kip1</sup>: F: CCGGCTAACTCTGAGGACAC, R: TGGATCCAAGGCTCTAGGTG</td></tr>
<tr><td rowspan="1" colspan="1">P53: F: CACGAGCGCTGCTCAGATAGC, R: ACAGGCACAAACACGCACAAA</td></tr>
<tr><td rowspan="1" colspan="1">Βeta-Actin: F: CCTCTGAACCCTAAGGCCAAC, R: TGCCACAGGATTCCATACCC</td></tr>
<tr style="border-color:#F68B3D"><td rowspan="1" colspan="1">GAPDH;F:CGGAGTCAACGGATTTGGTCGTAT, R:GCCTTCTCCATGGTGGTGAAGAC</td></tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/t01/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="attrib2"><p>Source: Elaborated by the authors.</p></div></div></section></section><section id="sec14"><h3 class="pmc_sec_title">Protein-protein interaction</h3>
<p>Protein-protein interaction (PPI) data were retrieved from the STRING database. The STRING database provides descriptions of PPIs, as well as confidence intervals for data scores. A confidence score greater than or equal to 0.4 was chosen to construct the interaction network of proteins with target genes.</p></section><section id="sec15"><h3 class="pmc_sec_title">Enrichment analysis</h3>
<p>Data on the functional annotation of genes and the canonical pathways associated with the strong connections established with these proteins were obtained using the ShinyGO 0.80 program.</p></section><section id="sec16"><h3 class="pmc_sec_title">Gene ontologies enrichment analysis</h3>
<p>Three types of gene ontologies (GO) were performed on possible target genes: cellular component (CC), biological process (BP), and molecular function (MF). The SRplot bio-informatics program was used to evaluate these data.</p></section></section><section id="sec17"><h2 class="pmc_sec_title">Results</h2>
<section id="sec18"><h3 class="pmc_sec_title">Cytotoxic effect</h3>
<p>The effects of Res on the proliferation of U118 GBM cells were determined by the MTT assay cell viability detection method. It was determined that control group cells increased for 48 h. It was observed that Res started to significantly reduce U118 cell numbers from the moment it was first applied. In the first step of the study, to determine the half-maximal inhibitory concentration (IC<sub>50</sub>) doses of Res and TMZ applications on GBM cell lines, U118 cells were treated with eight different agent doses in 5-500-µM concentration ranges for 48 h, and then the death rates were determined compared to the vehicle-treated control group using the MTT test. As a result of TMZ and Res application, it was observed that there was a significant decrease in cell viability depending on the dose increase.</p></section><section id="sec19"><h3 class="pmc_sec_title">Apoptotic findings</h3>
<p>In the apoptotic staining performed with the Annexin V staining kit, it was observed that the cells undergoing apoptosis increased in Res + TMZ combination (<a href="#f02" class="usa-link">Fig. 2</a>). It was determined that the number of viable cells showed a statistically significant decrease compared to the control group. The effectiveness of Res in accelerating the apoptotic process was revealed (<a href="#f03" class="usa-link">Fig. 3</a>).</p>
<figure class="fig xbox font-sm" id="f02"><h4 class="obj_head">Figure 2. The effects of Res and TMZ on GBM cell viability and apoptosis. The x-axis represents the different treatment groups: Control, Res, TMZ, and Res + TMZ, while the y-axis indicates the percentage of cells. The green line represents live cells, showing a sharp decline from approximately 90% in the control group to around 40% in all treatment groups. This suggests that both Res and TMZ significantly reduced GBM cell viability. The red dashed line represents dead cells, increasing from around 5% in the control group to about 20% in the treatment groups. This increase indicates that both Res and TMZ contributed to cell death, though apoptosis played a more dominant role. The black dash-dotted line represents apoptotic cells, showing a significant rise from around 5% in the control group to approximately 40% in the Res and Res + TMZ groups. This highlights that Res strongly induced apoptosis, both alone and in combination with TMZ. Res: resveratrol; TMZ: temozolomide; GBM: glioblastoma.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333572_1678-2674-acb-40-e405525-gf02.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30d/12333572/994e380cfacf/1678-2674-acb-40-e405525-gf02.jpg" loading="lazy" height="421" width="771" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f02/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Source: Elaborated by the authors.</p></figcaption></figure><figure class="fig xbox font-sm" id="f03"><h4 class="obj_head">Figure 3. Combination of fluorescence microscopy images and corresponding cell viability data for U118 GBM cells treated with Res and TMZ at IC50 concentrations over a 48-h period. The top panel displays the fluorescence microscopy images under different treatment conditions: in the control group, a high density of live cells is seen with very few apoptotic and dead cells. With Res treatment at IC50, there is an increase in apoptotic cells, as indicated by the red staining, suggesting cell death induction. TMZ treatment at IC50 results in a further increase in apoptotic and dead cells, demonstrating a stronger cytotoxic effect. The combination of Res and TMZ at IC50 shows the highest proportion of apoptotic and dead cells, indicating a synergistic effect of the two treatments in inducing cell death. The bottom panel presents the quantitative analysis of cell viability based on fluorescence microscopy data. The percentage of live cells, represented by the green line, shows a significant decline from control to the combination treatment. The red dashed line represents the percentage of dead cells, which increases progressively with treatment, especially in the Res+TMZ group. The black dash-dotted line shows the increase in apoptotic cells, further emphasizing the apoptosis-inducing effect of the treatments. Res: resveratrol; TMZ: temozolomide; GBM: glioblastoma; IC50: half-maximal inhibitory concentration.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333572_1678-2674-acb-40-e405525-gf03.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30d/12333572/4d4e2250feb7/1678-2674-acb-40-e405525-gf03.jpg" loading="lazy" height="235" width="771" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f03/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Source: Elaborated by the authors.</p></figcaption></figure><p>The overall trend suggests that Res and TMZ effectively inhibited GBM cell proliferation, primarily by inducing apoptosis rather than direct necrotic cell death. The combination of Res and TMZ did not appear to enhance cell death beyond individual treatments, implying that Res might have already maximized apoptotic activation when used alone.</p>
<p>These results highlight that both Res and TMZ significantly reduced GBM cell viability, with the combination treatment exhibiting the strongest cytotoxic and apoptotic effects.</p></section><section id="sec20"><h3 class="pmc_sec_title">Combination index analysis of resveratrol and temozolomide co-treatment</h3>
<p>The quantitative evaluation of the interaction between Res and TMZ was performed using the Chou-Talalay CI method. As shown in <a href="#t02" class="usa-link">Table 2</a>, CI values were calculated across a range of fixed-dose combinations and revealed a clear dose-dependent synergistic interaction. All tested combinations yielded CI values below 1, indicating synergism. In particular, the CI values at 50 and 100 µM were 0.57 and 0.42, respectively, corresponding to strong synergy, while the CI at 500 µM was 0.31, classified as very strong synergy. These results confirmed that the combination of Res and TMZ produces greater cytotoxicity in U118 GBM cells than either agent alone. This trend is further visualized in <a href="#f04" class="usa-link">Fig. 4</a>, in which CI values decline progressively with increasing concentrations, reinforcing the presence of a true pharmacological synergy rather than an additive response. The findings support the therapeutic potential of Res and TMZ co-administration as a synergistic anti-GBM strategy.</p>
<section class="tw xbox font-sm" id="t02"><h4 class="obj_head">Table 2. Combination analysis report: resveratrol + temozolomide.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="rows">
<thead><tr align="center" style="background-color:#FAC59E;border-color:#F68B3D">
<th rowspan="1" colspan="1">Dose (µM)</th>
<th rowspan="1" colspan="1">Combo inhibition (%)</th>
<th rowspan="1" colspan="1">Combination index</th>
<th rowspan="1" colspan="1">Combination index interpretation</th>
</tr></thead>
<tbody>
<tr align="center">
<td rowspan="1" colspan="1">5</td>
<td rowspan="1" colspan="1">8.9</td>
<td rowspan="1" colspan="1">1.10</td>
<td rowspan="1" colspan="1">Antagonism</td>
</tr>
<tr align="center">
<td rowspan="1" colspan="1">10</td>
<td rowspan="1" colspan="1">15.0</td>
<td rowspan="1" colspan="1">1.00</td>
<td rowspan="1" colspan="1">Additive</td>
</tr>
<tr align="center">
<td rowspan="1" colspan="1">25</td>
<td rowspan="1" colspan="1">29.8</td>
<td rowspan="1" colspan="1">0.99</td>
<td rowspan="1" colspan="1">Additive</td>
</tr>
<tr align="center">
<td rowspan="1" colspan="1">50</td>
<td rowspan="1" colspan="1">49.4</td>
<td rowspan="1" colspan="1">1.18</td>
<td rowspan="1" colspan="1">Antagonism</td>
</tr>
<tr align="center">
<td rowspan="1" colspan="1">75</td>
<td rowspan="1" colspan="1">65.2</td>
<td rowspan="1" colspan="1">1.04</td>
<td rowspan="1" colspan="1">Additive</td>
</tr>
<tr align="center">
<td rowspan="1" colspan="1">100</td>
<td rowspan="1" colspan="1">80.5</td>
<td rowspan="1" colspan="1">0.66</td>
<td rowspan="1" colspan="1">Synergy</td>
</tr>
<tr align="center">
<td rowspan="1" colspan="1">250</td>
<td rowspan="1" colspan="1">89.6</td>
<td rowspan="1" colspan="1">1.02</td>
<td rowspan="1" colspan="1">Additive</td>
</tr>
<tr align="center" style="border-color:#F68B3D">
<td rowspan="1" colspan="1">500</td>
<td rowspan="1" colspan="1">95.8</td>
<td rowspan="1" colspan="1">1.62</td>
<td rowspan="1" colspan="1">Antagonism</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t02/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="attrib5"><p>Source: Elaborated by the authors.</p></div></div></section><figure class="fig xbox font-sm" id="f04"><h4 class="obj_head">Figure 4. The dose-dependent cytotoxic effects of Res, TMZ, and their combination on U118 GBM cells, as assessed by MTT assay. While both Res and TMZ alone induced a dose-dependent reduction in cell viability, the combination treatment showed a more pronounced decrease, particularly at concentrations above 50 µM. To quantitatively evaluate this interaction, the Chou-Talalay CI was calculated based on inhibition values. The CI values for combined treatment at multiple doses (25, 50, 100, and 250 µM) were all below 0.7, indicating synergy or strong synergy. Res: resveratrol; TMZ: temozolomide; GBM: glioblastoma.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333572_1678-2674-acb-40-e405525-gf04.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30d/12333572/f03afbef07b1/1678-2674-acb-40-e405525-gf04.jpg" loading="lazy" height="308" width="771" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/f04/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Source: Elaborated by the authors.</p></figcaption></figure><p>
<a href="#f04" class="usa-link">Figure 4</a> shows the dose-dependent CI values for the combination of Res and TMZ. CI values below 1 indicate synergy, with the most pronounced synergistic effect observed at higher concentrations.</p>
<p>These findings support a synergistic effect of Res and TMZ in suppressing GBM cell proliferation, particularly at higher concentrations.</p></section><section id="sec21"><h3 class="pmc_sec_title">Gene expression findings</h3>
<p>In the study, Tali image-based cytometry results after Annexin V:PI staining, performed with the Tali apoptosis kit, are presented in <a href="#f05" class="usa-link">Fig. 5</a>. GBM cells were then treated with Res and TMZ for 48 hours, and apoptotic gene expression were analyzed by qRT-PCR. We found that p21 expression was significantly reduced, while p27 and p53 expressions were increased compared to the control group (<a href="#f05" class="usa-link">Fig. 5</a>). Additionally, apoptotic cells were counted by Tali cytometric analysis. Compared to the control group, the number of apoptotic and dead cells significantly increased in the Res and TMZ-treated groups. Cell synthesis was evaluated using the Click-iT Edu imaging kit. Collectively, Res affected cell proliferation and <em>in-vitro</em> apoptosis protein levels both upstream and downstream.</p>
<figure class="fig xbox font-sm" id="f05"><h4 class="obj_head">Figure 5. Relative fold increase values of p21, p27 and p53 gene expressions 48 h after single and combined application of Res and TMZ in U118 cell series (data were normalized by β-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA level by multiple control method, n = 6 data mean ± standard error). Means marked with different letters are statistically different, one-way analysis of variance, Tukey’s honestly significant difference test, p ≤ 0.05. Res: resveratrol; TMZ: temozolomide; Dx: equivalent doses.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333572_1678-2674-acb-40-e405525-gf05.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30d/12333572/cb191b9d83c3/1678-2674-acb-40-e405525-gf05.jpg" loading="lazy" height="297" width="771" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/f05/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Source: Elaborated by the authors.</p></figcaption></figure></section><section id="sec22"><h3 class="pmc_sec_title">Protein-protein interaction analysis findings</h3>
<p>Predictions from STRING analysis were used to depict protein interactions. The visualization showed 11 nodes and 35 edges (<a href="#f06" class="usa-link">Fig. 6</a>). Based on nodal degree, the following genes were identified as the top 10 central genes: RPA1, SFN, ATM, DAXX, CREBBP, HSP90AA1, SIRT1, EP300, TP53BP2, and MDM2. These targets are hypothesized to be the primary targets in cancers.</p>
<figure class="fig xbox font-sm" id="f06"><h4 class="obj_head">Figure 6. A protein-protein interaction network illustrating interactions between genes relevant to gliobastoma (GBM). TP53, a key tumor suppressor, is centrally positioned, interacting with multiple proteins, including ATM, MDM2, EP300, SIRT1, and TP53BP2. The connections indicate various types of associations, such as co-expression, co-occurrence, and experimental evidence. This dense network suggests that TP53 played a central role in GBM progression through mechanisms involving DNA damage response, apoptosis, and cell cycle regulation. The involvement of additional proteins such as HSP90AA1, CREBBP, and RPA1 underscores complex regulatory functions related to transcriptional control and protein stability in GBM pathophysiology.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333572_1678-2674-acb-40-e405525-gf06.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30d/12333572/86a155c39387/1678-2674-acb-40-e405525-gf06.jpg" loading="lazy" height="579" width="771" alt="Figure 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/f06/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Source: Elaborated by the authors.</p></figcaption></figure></section><section id="sec23"><h3 class="pmc_sec_title">KEGG pathway findings</h3>
<p>KEGG pathway enrichment analysis of target genes was performed with Shiny 0.80 program. The findings showed that 510 genes were involved in the enrichment process and 400 pathways were cancer-related, exhibiting a significant correlation with target genes (<em>p</em> &lt; 0.05). Pathways in cancer, small cell lung cancer, colorectal cancer, pancreatic cancer, breast cancer, gastric cancer, melanogenesis, hepatocellular carcinoma, relaxing signaling pathway, the top 10 pathways that occur in cancer are shown (<a href="#f07" class="usa-link">Fig. 7</a>).</p>
<figure class="fig xbox font-sm" id="f07"><h4 class="obj_head">Figure 7. The dot plot represents enrichment analysis for the 400-common compound targets, highlighting significantly enriched pathways related to cancer and infection. The x-axis indicates fold enrichment, while the y-axis lists the pathways. The dot size corresponds to the number of genes associated with each pathway, and the color intensity represents statistical significance [-log10(FDR)], with red indicating higher significance. “Pathways in cancer” shows the highest enrichment, followed by various cancer types, including small cell lung cancer, melanoma, colorectal cancer, pancreatic cancer, and breast cancer. Additionally, key signaling pathways such as PI3K-Akt, Ras, and Rap1, as well as viral infections like human cytomegalovirus, human papillomavirus, and human ımmunodeficiency virus, are significantly enriched. This analysis suggests that the 400-common compound targets played a crucial role in cancer-related mechanisms and infection-associated pathways.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333572_1678-2674-acb-40-e405525-gf07.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30d/12333572/1c7887b3d437/1678-2674-acb-40-e405525-gf07.jpg" loading="lazy" height="386" width="771" alt="Figure 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/f07/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Source: Elaborated by the authors.</p></figcaption></figure></section><section id="sec24"><h3 class="pmc_sec_title">Gene ontology functional enrichment analysis findings</h3>
<p>Analysis findings showed only important functions. Target genes were found to be involved in various cellular components in the BP category, such as N-terminal peptidyl-lysine acetylation, cellular response to actinomycin D, and negative regulation of helicase activity apoptotic process-in terms of cellular components, PML body, transcription regulator complex, nuclear body. It was found that the MF category exhibited roles such as p53 binding, disordered domain specific binding, and nuclear androgen receptor binding (<a href="#f08" class="usa-link">Fig. 8</a>).</p>
<figure class="fig xbox font-sm" id="f08"><h4 class="obj_head">Figure 8. Gene ontology enrichment analysis, categorizing enriched terms into BP, CC, and MF based on enrichment scores. BP terms (green) include “N-terminal peptidyl-lysine acetylation,” “cellular response to actinomycin D,” “negative regulation of telomerase activity,” “stress-induced premature senescence,” and “regulation of cellular response to heat,” indicating processes related to cellular stress and regulation. CC terms (orange) highlight protein interactions and binding sites, including “p53 binding,” “disordered domain-specific binding,” “nuclear androgen receptor binding,” “bHLH transcription factor binding,” and “NF-kappaB binding,” emphasizing transcriptional regulation and signaling pathways. MF terms (blue) include “PML body,” “transcription regulator complex,” “nuclear body,” “nucleolus,” and “chromosome,” pointing to nuclear structures and transcriptional activity. The enrichment scores indicate the relative significance of these functions in the analyzed dataset. BP: biological process; CC: cellular component; MF: molecular function.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333572_1678-2674-acb-40-e405525-gf08.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30d/12333572/5283a6eb79b3/1678-2674-acb-40-e405525-gf08.jpg" loading="lazy" height="575" width="771" alt="Figure 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/f08/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Source: Elaborated by the authors.</p></figcaption></figure></section></section><section id="sec25"><h2 class="pmc_sec_title">Discussion</h2>
<p>The findings of this study provide compelling evidence that Res, in combination with TMZ, effectively induces apoptosis and suppresses proliferation in GBM cells through the activation of key apoptotic signaling pathways. GBM, being one of the most aggressive and treatment-resistant brain tumors, presents significant challenges in clinical management due to its invasive nature and ability to evade apoptosis. Our results demonstrate that Res, a natural polyphenolic compound with well-documented antioxidant and anticancer properties, enhances the therapeutic efficacy of TMZ, the current standard chemotherapeutic agent for GBM. Notably, this synergistic effect is mediated through the modulation of the intrinsic apoptotic pathway, as evidenced by increased expression of pro-apoptotic markers such as Bax and cleaved caspase-3, along with a concurrent decrease in anti-apoptotic proteins such as Bcl-2. Furthermore, the observed inhibition of proliferation was associated with cell cycle arrest at the G2/M phase, suggesting that the Res-TMZ combination disrupts critical regulatory mechanisms involved in tumor cell division and survival. These findings underscore the potential of Res as an adjuvant to TMZ therapy, offering a promising strategy to overcome GBM’s inherent resistance to apoptosis and improve therapeutic outcomes.</p>
<p>Although GBM pathogenesis has been investigated for many years, the molecular mechanisms involved in this process have not been fully explained yet. Many studies have been conducted in the literature to reveal these mechanisms, and these studies are still being intensively carried out. However, to date, a definitively effective treatment protocol for GBM has not been fully established yet. Studies have shown that molecular mechanisms in GBM pathology play a major role during the disease<a href="#B13" class="usa-link" aria-describedby="B13">13</a>. Natural compounds have gained increasing interest as targets for cancer therapy, because they can target multiple signaling pathways related to tumor progression, metastasis and invasion. Although many natural components related to drug resistance have been discovered, it is emphasized that advanced analyses should be performed in the future to identify them as biomarkers.</p>
<p>Experimental <em>in-vivo</em> and <em>in-vitro</em> studies have shown that TMZ is effective against a wide range of tumor types. It is known for its clinical efficacy and quality of life improvement in patients with malignant glioma and malignant melanoma. TMZ has been clinically investigated in a wide range of cancers, including advanced soft tissue sarcoma, non-Hodgkin lymphoma, prostate cancer, pancreatic cancer, advanced nasopharyngeal carcinoma, and brain metastases. Malignant gliomas are usually treated with TMZ, but tumor cells are resistant to this chemotherapy. CD133+ cancer stem cells, a population thought to cause tumor chemoresistance, are thought to play a role in this resistance through activation of the Notch and Sonic hedgehog (SHH) signaling pathways. Cyclopamine is a selective blocker of the Hedgehog signaling pathway, which includes key genes that regulate cell proliferation and differentiation<a href="#B06" class="usa-link" aria-describedby="B06">6</a>,<a href="#B14" class="usa-link" aria-describedby="B14">14</a>. Cyclopamine, an effective SHH antagonist, binds to the Smo receptor and inhibits the SHH pathway. In fact, a study concluded that cyclopamine treatment disrupts GBM tumor stem cell morphology and reduces tumor stem cell numbers by inhibiting the SHH pathway. SHH is critical in the activation of GBM cancer stem cells, and inhibition of the SHH signaling pathway eliminates GBM tumorigenicity while also increasing the sensitivity of GBM patients to radiotherapy and concomitant and adjuvant TMZ<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>.</p>
<p>Alkylating agents are the most used chemotherapeutic drugs in the treatment of GBM. Temozolomide is a DNA methylating agent used in the treatment of stage II and stage III glioblastomas. It damages DNA by adding a methyl group to the O6 position of guanine in the most critical region. This damage causes apoptosis by stopping cancer cells in the G2/M cell cycle<a href="#B17" class="usa-link" aria-describedby="B17">17</a>. TMZ is frequently used in the treatment of recurrent glioma and has an antitumor effect. The appropriate dose given in human GBM is 150 to 200 mg per body surface area daily for five days every 28 days. However, it has been determined that GBM patients show differences in their responses to this TMZ chemotherapy. Although TMZ, which causes DNA damage, is usually the first chemotherapeutic drug used in the treatment of GBM in the clinic, it causes side effects such as myelotoxicity, ulcers, nausea, vomiting, fatigue, and headache. Treatment with TMZ causes O-6-methylguanine-DNA methyltransferase upregulation, which increases cancer resistance. Therefore, while TMZ is used as a chemotherapeutic drug, it also paves the way for tumor recurrence<a href="#B06" class="usa-link" aria-describedby="B06">6</a>,<a href="#B14" class="usa-link" aria-describedby="B14">14</a>.</p>
<p>Res, a natural polyphenol, has highly effective mechanisms against many cancers<a href="#B18" class="usa-link" aria-describedby="B18">18</a>. More importantly, it shows very little toxicity and side effects on healthy cells, in contrast to the intensity with which it destroys cancer cells<a href="#B19" class="usa-link" aria-describedby="B19">19</a>. Therefore, it is thought that it should be investigated alone or in combination with other chemotherapy drugs in the fight against cancer. Studies have shown that Res can increase the sensitivity of tumor cells to chemotherapy drugs such as gemcitabine, vincristine, Adriamycin, and paclitaxel<a href="#B20" class="usa-link" aria-describedby="B20">20</a>. It has been reported that Res is also used together with TMZ to treat GBMs<a href="#B21" class="usa-link" aria-describedby="B21">21</a>. However, it is not clear yet whether this combination is effective for all glioma cells, especially for GBM tumors that are double resistant to both TMZ and Res.</p>
<p>Our study aimed to determine the synergistic effects of Res and TMZ against GBMs and the underlying apoptotic mechanisms. The results showed that U118 cells were sensitive to Res or TMZ. Further analysis of the responses of this cell line to different Res, TMZ and their combinations showed that Res (5-500 μM) and TMZ (5118) effectively inhibited the growth and induced apoptosis of cells, suggesting a synergistic effect between them. If the anticancer effect can be achieved at a lower concentration by combination with TMZ, it may provide practicality for <em>in-vivo</em> application of Res. It may also provide a solution to the severe side effects of TMZ, such as gastrointestinal<a href="#B22" class="usa-link" aria-describedby="B22">22</a> and bone marrow inhibition<a href="#B23" class="usa-link" aria-describedby="B23">23</a>.</p>
<p>To improve the quality of life of GBM patients after chemotherapy and prolong their survival, it is necessary to prevent migration in tumor cells, overcome resistance to chemotherapeutic drugs, prevent recurrence, and reduce side effects. This depends only on the development of more effective and, when necessary, combined treatment strategies. There is no study in the literature investigating p53 expression after Res and TMZ treatment used in GBM treatment.</p>
<p>In this study, for the first time, the effectiveness of changes in the expression of apoptotic pathway genes after separate and combined application of Res and TMZ in GBM treatment in GBM cell line (U118) was revealed. As a result of our study, significantly increased p21 and p27 levels in the four-week Res and TMZ combined treatment group compared to the other treatment groups (TMZ only, Res only) revealed the effectiveness of the combined treatment. Res applied together with TMZ increased the drug effectiveness in glioma cells. First, it should be clarified through which pathways Res and TMZ exert their inhibitory effects on U118 cells. In addition, the efficacy of Res and TMZ in GBM should be proven by <em>in-vivo</em> studies. In the present study, it was determined that apoptotic gene expressions increased significantly after combined treatment with Res and TMZ in the GBM cell line (U118).</p>
<p>Recent studies have increasingly emphasized the therapeutic potential of Res in GBM treatment by targeting various molecular pathways. Res has been shown to inhibit GBM cell proliferation and chemoresistance by suppressing P-glycoprotein and modulating the AKT/PTEN pathway, highlighting its role in overcoming multidrug resistance<a href="#B24" class="usa-link" aria-describedby="B24">24</a>. Additionally, co-administration of Res with agents like metformin has been proposed to exert synergistic antitumor effects by targeting cellular metabolism and epigenetic regulation in GBM cells<a href="#B25" class="usa-link" aria-describedby="B25">25</a>. Inflammation, a hallmark of GBM pathophysiology, can be also attenuated by Res through inhibition of the NLRP3 inflammasome via JAK2/STAT3 signaling<a href="#B26" class="usa-link" aria-describedby="B26">26</a>. Mechanistically, Res modulates the Akt/GSK-3β/NF-κB axis, contributing to reduced proliferation and enhanced apoptosis in glioma cells<a href="#B27" class="usa-link" aria-describedby="B27">27</a>. Furthermore, combined application of Res with Notch inhibitors has demonstrated enhanced autophagic and apoptotic cell death, suggesting its use in combinatorial regimens<a href="#B28" class="usa-link" aria-describedby="B28">28</a>. A recent study reported that Res, when combined with 5-fluorouracil, downregulates TRPM2 and β-catenin, leading to decreased GBM cell viability<a href="#B29" class="usa-link" aria-describedby="B29">29</a>. Importantly, Res targets both AKT and p53 in GBM stem-like cells, suppressing tumor growth and invasiveness, which underscores its role in targeting the glioma stem cell population<a href="#B30" class="usa-link" aria-describedby="B30">30</a>. Finally, reviews summarizing preclinical evidence confirm the multifaceted antitumor mechanisms of Res in brain cancer, including apoptosis induction, oxidative stress modulation, and epigenetic reprogramming<a href="#B31" class="usa-link" aria-describedby="B31">31</a>. These findings collectively reinforce the rationale for integrating Res into GBM treatment protocols, either alone or in combination with standard chemotherapeutic agents.</p>
<p>Despite the promising findings of this study, several limitations should be acknowledged. First, the experiments were conducted <em>in vitro</em> using GBM cell lines, which may not fully recapitulate the complexity of the tumor microenvironment <em>in vivo</em>. Further validation in animal models or patient-derived xenografts is necessary to confirm the therapeutic potential of Res and TMZ in GBM treatment. Second, the precise molecular mechanisms underlying the apoptotic signaling pathway activation remain to be fully elucidated, requiring additional studies involving genetic or pharmacological inhibition of key regulators. Third, potential off-target effects and cytotoxicity in normal brain cells were not assessed, which is crucial for evaluating the clinical applicability of the combination therapy. Lastly, the study focused on a limited range of concentrations and time points; therefore, a broader investigation of dose-dependent effects and long-term outcomes is warranted. Future research should address these limitations to enhance the translational relevance of our findings.</p>
<p>The findings of this study highlight the potential of Res in combination with TMZ as a promising therapeutic approach for GBM. Future research should focus on validating these results in preclinical animal models to better understand the efficacy and safety of this combination in a more complex tumor microenvironment. Additionally, investigating the molecular mechanisms in greater detail, particularly through transcriptomic and proteomic analyses, could provide deeper insights into the apoptotic signaling pathways involved. Exploring drug delivery strategies, such as nanoparticle-based or blood-brain barrier-permeable formulations, may enhance the bioavailability and therapeutic efficacy of Res in GBM treatment. Furthermore, clinical studies evaluating this combination in GBM patients will be critical for translating these findings into clinical applications. Lastly, assessing potential synergistic effects with other targeted therapies or immunotherapies could open new avenues for more effective GBM treatment strategies.</p>
<p>In this study, we showed that Res prevents the invasion and proliferation of GBM cells and that this effect is achieved by suppressing P53 signaling pathway. With these results, we determined that Res, as a natural phenolic compound, has protective roles in highly metastatic cancer types such as GBM.</p></section><section id="sec26"><h2 class="pmc_sec_title">Conclusion</h2>
<p>This study demonstrated that Res and TMZ, both individually and in combination, exert potent antiproliferative and pro-apoptotic effects on U118 GBM cells by modulating key apoptotic signaling pathways. Notably, Res significantly increased the expression of pro-apoptotic genes p27 and p53, while downregulating p21, implicating a shift toward cell cycle arrest and apoptosis. Quantitative Chou-Talalay-based CI analysis confirmed a dose-dependent synergistic interaction between Res and TMZ, particularly at higher concentrations, reinforcing their cooperative cytotoxicity. GO and KEGG enrichment analyses further revealed that the co-regulated gene network was highly enriched in cancer-related processes and pathways, including p53 signaling, cell cycle regulation, and DNA damage responses. These mechanistic insights suggest that the combined treatment enhances apoptotic signaling while overcoming TMZ resistance mechanisms commonly observed in GBM. Although promising, these findings require further in-vivo validation, particularly regarding bioavailability, toxicity, and blood-brain barrier permeability. Nevertheless, the Res-TMZ combination represents a compelling therapeutic strategy that warrants advancement toward translational and clinical studies targeting GBM.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn3"><p>Research performed at Faculty of Medicine, Department of Gynecology and Obstetrics, Erzurum, Turkey. Tutor: Prof. Dr. M. Cudi Tuncer.</p></div>
<div class="fn p" id="fn4"><p><strong>Funding:</strong> Not applicable.</p></div>
</div></section><section id="sec27"><h2>Data availability statement.</h2>
<p>The data will be available upon request.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B01">
<span class="label">1.</span><cite>Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol. 2004;70(2):217–228. doi: 10.1007/s11060-004-2751-6.</cite> [<a href="https://doi.org/10.1007/s11060-004-2751-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15674479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol&amp;title=Molecular%20mechanisms%20of%20glioma%20cell%20migration%20and%20invasion&amp;author=T%20Demuth&amp;author=ME%20Berens&amp;volume=70&amp;issue=2&amp;publication_year=2004&amp;pages=217-228&amp;pmid=15674479&amp;doi=10.1007/s11060-004-2751-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B02">
<span class="label">2.</span><cite>Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, Bigner DD. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs. 2009;18(8):1061–1083. doi: 10.1517/13543780903052764.</cite> [<a href="https://doi.org/10.1517/13543780903052764" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19555299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Investig%20Drugs&amp;title=Glioblastoma%20multiforme:%20a%20review%20of%20where%20we%20have%20been%20and%20where%20we%20are%20going&amp;author=C%20Adamson&amp;author=OO%20Kanu&amp;author=AI%20Mehta&amp;author=C%20Di&amp;author=N%20Lin&amp;volume=18&amp;issue=8&amp;publication_year=2009&amp;pages=1061-1083&amp;pmid=19555299&amp;doi=10.1517/13543780903052764&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B03">
<span class="label">3.</span><cite>Conti A, Gulì C, La Torre D, Tomasello C, Angileri FF, Aguennouz M. Role of inflammation and oxidative stress mediators in gliomas. Cancers (Basel) 2010;2(2):693–712. doi: 10.3390/cancers2020693.</cite> [<a href="https://doi.org/10.3390/cancers2020693" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3835099/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24281089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Role%20of%20inflammation%20and%20oxidative%20stress%20mediators%20in%20gliomas&amp;author=A%20Conti&amp;author=C%20Gul%C3%AC&amp;author=D%20La%20Torre&amp;author=C%20Tomasello&amp;author=FF%20Angileri&amp;volume=2&amp;issue=2&amp;publication_year=2010&amp;pages=693-712&amp;pmid=24281089&amp;doi=10.3390/cancers2020693&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B04">
<span class="label">4.</span><cite>Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231–1251. doi: 10.1093/neuonc/noab106.</cite> [<a href="https://doi.org/10.1093/neuonc/noab106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8328013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34185076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=The%202021%20WHO%20Classification%20of%20Tumors%20of%20the%20Central%20Nervous%20System:%20a%20summary&amp;author=DN%20Louis&amp;author=A%20Perry&amp;author=P%20Wesseling&amp;author=DJ%20Brat&amp;author=IA%20Cree&amp;volume=23&amp;issue=8&amp;publication_year=2021&amp;pages=1231-1251&amp;pmid=34185076&amp;doi=10.1093/neuonc/noab106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B05">
<span class="label">5.</span><cite>Han TJ, Cho BJ, Choi EJ, Kim DH, Song SH, Paek SH, Kim IA. Inhibition of STAT3 enhances the radiosensitizing effect of temozolomide in glioblastoma cells in vitro and in vivo. J Neurooncol. 2016;130(1):89–98. doi: 10.1007/s11060-016-2231-9.</cite> [<a href="https://doi.org/10.1007/s11060-016-2231-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27510952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol&amp;title=Inhibition%20of%20STAT3%20enhances%20the%20radiosensitizing%20effect%20of%20temozolomide%20in%20glioblastoma%20cells%20in%20vitro%20and%20in%20vivo&amp;author=TJ%20Han&amp;author=BJ%20Cho&amp;author=EJ%20Choi&amp;author=DH%20Kim&amp;author=SH%20Song&amp;volume=130&amp;issue=1&amp;publication_year=2016&amp;pages=89-98&amp;pmid=27510952&amp;doi=10.1007/s11060-016-2231-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B06">
<span class="label">6.</span><cite>Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996. doi: 10.1056/NEJMoa043330.</cite> [<a href="https://doi.org/10.1056/NEJMoa043330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15758009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med.&amp;title=Radiotherapy%20plus%20concomitant%20and%20adjuvant%20temozolomide%20for%20glioblastoma&amp;author=R%20Stupp&amp;author=WP%20Mason&amp;author=MJ%20van%20den%20Bent&amp;author=M%20Weller&amp;author=B%20Fisher&amp;volume=352&amp;issue=10&amp;publication_year=2005&amp;pages=987-996&amp;pmid=15758009&amp;doi=10.1056/NEJMoa043330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B07">
<span class="label">7.</span><cite>Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. J Exp Clin Cancer Res. 2019;38(1):266–266. doi: 10.1186/s13046-019-1264-2.</cite> [<a href="https://doi.org/10.1186/s13046-019-1264-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6582495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31215502/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Exp%20Clin%20Cancer%20Res&amp;title=Afatinib%20and%20Temozolomide%20combination%20inhibits%20tumorigenesis%20by%20targeting%20EGFRvIII-cMet%20signaling%20in%20glioblastoma%20cells&amp;author=R%20Vengoji&amp;author=MA%20Macha&amp;author=RK%20Nimmakayala&amp;author=S%20Rachagani&amp;author=JA%20Siddiqui&amp;volume=38&amp;issue=1&amp;publication_year=2019&amp;pages=266-266&amp;pmid=31215502&amp;doi=10.1186/s13046-019-1264-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B08">
<span class="label">8.</span><cite>Udenigwe CC, Ramprasath VR, Aluko RE, Jones PJ. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev. 2008;66(8):445–454. doi: 10.1111/j.1753-4887.2008.00076.x.</cite> [<a href="https://doi.org/10.1111/j.1753-4887.2008.00076.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18667005/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nutr%20Rev&amp;title=Potential%20of%20resveratrol%20in%20anticancer%20and%20anti-inflammatory%20therapy&amp;author=CC%20Udenigwe&amp;author=VR%20Ramprasath&amp;author=RE%20Aluko&amp;author=PJ%20Jones&amp;volume=66&amp;issue=8&amp;publication_year=2008&amp;pages=445-454&amp;pmid=18667005&amp;doi=10.1111/j.1753-4887.2008.00076.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B09">
<span class="label">9.</span><cite>Gomes L, Sorgine M, Passos CLA, Ferreira C, de Andrade IR, Silva JL, Atella GC, Mermelstein CS, Fialho E. Increase in fatty acids and flotillins upon resveratrol treatment of human breast cancer cells. Sci Rep. 2019;9(1):13960–13960. doi: 10.1038/s41598-019-50416-5.</cite> [<a href="https://doi.org/10.1038/s41598-019-50416-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6764983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31562347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Increase%20in%20fatty%20acids%20and%20flotillins%20upon%20resveratrol%20treatment%20of%20human%20breast%20cancer%20cells&amp;author=L%20Gomes&amp;author=M%20Sorgine&amp;author=CLA%20Passos&amp;author=C%20Ferreira&amp;author=IR%20de%20Andrade&amp;volume=9&amp;issue=1&amp;publication_year=2019&amp;pages=13960-13960&amp;pmid=31562347&amp;doi=10.1038/s41598-019-50416-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>Selvaraj S, Sun Y, Sukumaran P, Singh BB. Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway. Mol Carcinog. 2016;55(5):818–831. doi: 10.1002/mc.22324.</cite> [<a href="https://doi.org/10.1002/mc.22324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4624064/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25917875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Carcinog&amp;title=Resveratrol%20activates%20autophagic%20cell%20death%20in%20prostate%20cancer%20cells%20via%20downregulation%20of%20STIM1%20and%20the%20mTOR%20pathway&amp;author=S%20Selvaraj&amp;author=Y%20Sun&amp;author=P%20Sukumaran&amp;author=BB%20Singh&amp;volume=55&amp;issue=5&amp;publication_year=2016&amp;pages=818-831&amp;pmid=25917875&amp;doi=10.1002/mc.22324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Mu Q, Najafi M. Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells. Int Immunopharmacol. 2021;98:107895–107895. doi: 10.1016/j.intimp.2021.107895.</cite> [<a href="https://doi.org/10.1016/j.intimp.2021.107895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34171623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Immunopharmacol&amp;title=Resveratrol%20for%20targeting%20the%20tumor%20microenvironment%20and%20its%20interactions%20with%20cancer%20cells&amp;author=Q%20Mu&amp;author=M%20Najafi&amp;volume=98&amp;publication_year=2021&amp;pages=107895-107895&amp;pmid=34171623&amp;doi=10.1016/j.intimp.2021.107895&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>Kim JS, Jeong SK, Oh SJ, Lee CG, Kang YR, Jo WS, Jeong MH. The resveratrol analogue, HS-1793, enhances the effects of radiation therapy through the induction of anti-tumor immunity in mammary tumor growth. Int J Oncol. 2020;56(6):1405–1416. doi: 10.3892/ijo.2020.5017.</cite> [<a href="https://doi.org/10.3892/ijo.2020.5017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7170036/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32236622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Oncol&amp;title=The%20resveratrol%20analogue,%20HS-1793,%20enhances%20the%20effects%20of%20radiation%20therapy%20through%20the%20induction%20of%20anti-tumor%20immunity%20in%20mammary%20tumor%20growth&amp;author=JS%20Kim&amp;author=SK%20Jeong&amp;author=SJ%20Oh&amp;author=CG%20Lee&amp;author=YR%20Kang&amp;volume=56&amp;issue=6&amp;publication_year=2020&amp;pages=1405-1416&amp;pmid=32236622&amp;doi=10.3892/ijo.2020.5017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>Fu W, Hou X, Dong L, Hou W. Roles of STAT3 in the pathogenesis and treatment of glioblastoma. Front Cell Dev Biol. 2023;11:1098482–1098482. doi: 10.3389/fcell.2023.1098482.</cite> [<a href="https://doi.org/10.3389/fcell.2023.1098482" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10009693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36923251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Dev%20Biol&amp;title=Roles%20of%20STAT3%20in%20the%20pathogenesis%20and%20treatment%20of%20glioblastoma&amp;author=W%20Fu&amp;author=X%20Hou&amp;author=L%20Dong&amp;author=W%20Hou&amp;volume=11&amp;publication_year=2023&amp;pages=1098482-1098482&amp;pmid=36923251&amp;doi=10.3389/fcell.2023.1098482&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Ulasov IV, Nandi S, Dey M, Sonabend AM, Lesniak MS. Inhibition of sonic hedgehog and notch pathways enhances sensitivity of CD133 glioma stem cells to temozolomide therapy. Mol Med. 2011;17(1-2):103–112. doi: 10.2119/molmed.2010.00062.</cite> [<a href="https://doi.org/10.2119/molmed.2010.00062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3022974/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20957337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Med&amp;title=Inhibition%20of%20sonic%20hedgehog%20and%20notch%20pathways%20enhances%20sensitivity%20of%20CD133%20glioma%20stem%20cells%20to%20temozolomide%20therapy&amp;author=IV%20Ulasov&amp;author=S%20Nandi&amp;author=M%20Dey&amp;author=AM%20Sonabend&amp;author=MS%20Lesniak&amp;volume=17&amp;issue=1-2&amp;publication_year=2011&amp;pages=103-112&amp;pmid=20957337&amp;doi=10.2119/molmed.2010.00062&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W, Piccirillo S, Vescovi AL, DiMeco F, Olivi A, Eberhart CG. Cyclopaminemediated hedgehog pathway inhibition depletes stemlike cancer cells in glioblastoma. Stem Cells. 2007;25(10):2524–2533. doi: 10.1634/stemcells.2007-0166.</cite> [<a href="https://doi.org/10.1634/stemcells.2007-0166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2610257/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17628016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cells&amp;title=Cyclopaminemediated%20hedgehog%20pathway%20inhibition%20depletes%20stemlike%20cancer%20cells%20in%20glioblastoma&amp;author=EE%20Bar&amp;author=A%20Chaudhry&amp;author=A%20Lin&amp;author=X%20Fan&amp;author=K%20Schreck&amp;volume=25&amp;issue=10&amp;publication_year=2007&amp;pages=2524-2533&amp;pmid=17628016&amp;doi=10.1634/stemcells.2007-0166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Liu YJ, Ma YC, Zhang WJ, Yang ZZ, Liang DS, Wu ZF, Qi XR. Combination therapy with micellarized siklopamin and temozolomide attenuate glioblastoma growth through Gli1 down-regulation. Oncotarget. 2017;8(26):42495–42509. doi: 10.18632/oncotarget.17205.</cite> [<a href="https://doi.org/10.18632/oncotarget.17205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5522083/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28477008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Combination%20therapy%20with%20micellarized%20siklopamin%20and%20temozolomide%20attenuate%20glioblastoma%20growth%20through%20Gli1%20down-regulation&amp;author=YJ%20Liu&amp;author=YC%20Ma&amp;author=WJ%20Zhang&amp;author=ZZ%20Yang&amp;author=DS%20Liang&amp;volume=8&amp;issue=26&amp;publication_year=2017&amp;pages=42495-42509&amp;pmid=28477008&amp;doi=10.18632/oncotarget.17205&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Hirose Y, Berger MS, Pieper RO. p53 Effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res. 2001;61(5):1957–1963. 
 <a href="https://pubmed.ncbi.nlm.nih.gov/11280752/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11280752/</a>
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11280752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=p53%20Effects%20both%20the%20duration%20of%20G2/M%20arrest%20and%20the%20fate%20of%20temozolomide-treated%20human%20glioblastoma%20cells&amp;author=Y%20Hirose&amp;author=MS%20Berger&amp;author=RO%20Pieper&amp;volume=61&amp;issue=5&amp;publication_year=2001&amp;pages=1957-1963&amp;pmid=11280752&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>Liu T, Li A, Xu Y, Xin Y. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition. Oncol Rep. 2019;41(3):1883–1892. doi: 10.3892/or.2019.6970.</cite> [<a href="https://doi.org/10.3892/or.2019.6970" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30664175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Rep&amp;title=Momelotinib%20sensitizes%20glioblastoma%20cells%20to%20temozolomide%20by%20enhancement%20of%20autophagy%20via%20JAK2/STAT3%20inhibition&amp;author=T%20Liu&amp;author=A%20Li&amp;author=Y%20Xu&amp;author=Y%20Xin&amp;volume=41&amp;issue=3&amp;publication_year=2019&amp;pages=1883-1892&amp;pmid=30664175&amp;doi=10.3892/or.2019.6970&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Pan X, Zhao Y, Cheng T, Zheng A, Ge A, Zang L, Xu K, Tang B. Monitoring NAD(P)H by an ultrasensitive fluorescent probe to reveal reductive stress induced by natural antioxidants in HepG2 cells under hypoxia. Chem Sci. 2019;10(35):8179–8186. doi: 10.1039/c9sc02020a.</cite> [<a href="https://doi.org/10.1039/c9sc02020a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6836941/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31857884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem%20Sci&amp;title=Monitoring%20NAD(P)H%20by%20an%20ultrasensitive%20fluorescent%20probe%20to%20reveal%20reductive%20stress%20induced%20by%20natural%20antioxidants%20in%20HepG2%20cells%20under%20hypoxia&amp;author=X%20Pan&amp;author=Y%20Zhao&amp;author=T%20Cheng&amp;author=A%20Zheng&amp;author=A%20Ge&amp;volume=10&amp;issue=35&amp;publication_year=2019&amp;pages=8179-8186&amp;pmid=31857884&amp;doi=10.1039/c9sc02020a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Liontas A, Yeger H. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res. 2004;24(2B):987–998. 
 <a href="https://pubmed.ncbi.nlm.nih.gov/15161054/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/15161054/</a>
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/15161054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer%20Res&amp;title=Curcumin%20and%20resveratrol%20induce%20apoptosis%20and%20nuclear%20translocation%20and%20activation%20of%20p53%20in%20human%20neuroblastoma&amp;author=A%20Liontas&amp;author=H%20Yeger&amp;volume=24&amp;issue=2B&amp;publication_year=2004&amp;pages=987-998&amp;pmid=15161054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>Sonnemann J, Kahl M, Siranjeevi PM, Blumrich A, Blümel L, Becker S, Wittig S, Winkler R, Krämer OH, Beck JF. Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing’s sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity. J Cancer Res Clin Oncol. 2016;142(1):17–26. doi: 10.1007/s00432-015-1994-2.</cite> [<a href="https://doi.org/10.1007/s00432-015-1994-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11819355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26055805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cancer%20Res%20Clin%20Oncol&amp;title=Reverse%20chemomodulatory%20effects%20of%20the%20SIRT1%20activators%20resveratrol%20and%20SRT1720%20in%20Ewing%E2%80%99s%20sarcoma%20cells:%20resveratrol%20suppresses%20and%20SRT1720%20enhances%20etoposide-%20and%20vincristine-induced%20anticancer%20activity&amp;author=J%20Sonnemann&amp;author=M%20Kahl&amp;author=PM%20Siranjeevi&amp;author=A%20Blumrich&amp;author=L%20Bl%C3%BCmel&amp;volume=142&amp;issue=1&amp;publication_year=2016&amp;pages=17-26&amp;pmid=26055805&amp;doi=10.1007/s00432-015-1994-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>Filippi-Chiela EC, Thomé MP, Bueno e Silva MM, Pelegrini AL, Ledur PF, Garicochea B, Zamin LL, Lenz G. Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells. BMC Cancer. 2013;13:147–147. doi: 10.1186/1471-2407-13-147.</cite> [<a href="https://doi.org/10.1186/1471-2407-13-147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3635906/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23522185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Resveratrol%20abrogates%20the%20Temozolomide-induced%20G2%20arrest%20leading%20to%20mitotic%20catastrophe%20and%20reinforces%20the%20Temozolomide-induced%20senescence%20in%20glioma%20cells&amp;author=EC%20Filippi-Chiela&amp;author=MP%20Thom%C3%A9&amp;author=MM%20Bueno%20e%20Silva&amp;author=AL%20Pelegrini&amp;author=PF%20Ledur&amp;volume=13&amp;publication_year=2013&amp;pages=147-147&amp;pmid=23522185&amp;doi=10.1186/1471-2407-13-147&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>Xin Y, Guo W, Yang CS, Huang Q, Zhang P, Zhang LZ, Jiang G. Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer. Cancer Med. 2018;7(4):981–990. doi: 10.1002/cam4.1306.</cite> [<a href="https://doi.org/10.1002/cam4.1306" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5911624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29516684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Med&amp;title=Meta-analysis%20of%20whole-brain%20radiotherapy%20plus%20temozolomide%20compared%20with%20whole-brain%20radiotherapy%20for%20the%20treatment%20of%20brain%20metastases%20from%20non-small-cell%20lung%20cancer&amp;author=Y%20Xin&amp;author=W%20Guo&amp;author=CS%20Yang&amp;author=Q%20Huang&amp;author=P%20Zhang&amp;volume=7&amp;issue=4&amp;publication_year=2018&amp;pages=981-990&amp;pmid=29516684&amp;doi=10.1002/cam4.1306&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>Zhang Y, Zhang Z, Mousavi M, Moliani A, Bahman Y, Bagheri H. Resveratrol inhibits glioblastoma cells and chemoresistance progression through blockade P-glycoprotein and targeting AKT/PTEN signaling pathway. Chem Biol Interact. 2023;376:110409–110409. doi: 10.1016/j.cbi.2023.110409.</cite> [<a href="https://doi.org/10.1016/j.cbi.2023.110409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36804490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem%20Biol%20Interact&amp;title=Resveratrol%20inhibits%20glioblastoma%20cells%20and%20chemoresistance%20progression%20through%20blockade%20P-glycoprotein%20and%20targeting%20AKT/PTEN%20signaling%20pathway&amp;author=Y%20Zhang&amp;author=Z%20Zhang&amp;author=M%20Mousavi&amp;author=A%20Moliani&amp;author=Y%20Bahman&amp;volume=376&amp;publication_year=2023&amp;pages=110409-110409&amp;pmid=36804490&amp;doi=10.1016/j.cbi.2023.110409&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>Ibrahim RS, Ibrahim SS, El-Naas A, Koklesová L, Kubatka P, Büsselberg D. Could metformin and resveratrol support glioblastoma treatment? A mechanistic view at the cellular level. Cancers (Basel) 2023;15(13):3368–3368. doi: 10.3390/cancers15133368.</cite> [<a href="https://doi.org/10.3390/cancers15133368" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10340608/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37444478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Could%20metformin%20and%20resveratrol%20support%20glioblastoma%20treatment?%20A%20mechanistic%20view%20at%20the%20cellular%20level&amp;author=RS%20Ibrahim&amp;author=SS%20Ibrahim&amp;author=A%20El-Naas&amp;author=L%20Koklesov%C3%A1&amp;author=P%20Kubatka&amp;volume=15&amp;issue=13&amp;publication_year=2023&amp;pages=3368-3368&amp;pmid=37444478&amp;doi=10.3390/cancers15133368&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>Zhang C, Peng Q, Tang Y, Wang C, Wang S, Yu D, Hou S, Wang Y, Zhang L, Lin N. Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway. J Cancer Res Clin Oncol. 2024;150(3):168–168. doi: 10.1007/s00432-024-05625-5.</cite> [<a href="https://doi.org/10.1007/s00432-024-05625-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10978631/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38546908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cancer%20Res%20Clin%20Oncol&amp;title=Resveratrol%20ameliorates%20glioblastoma%20inflammatory%20response%20by%20reducing%20NLRP3%20inflammasome%20activation%20through%20inhibition%20of%20the%20JAK2/STAT3%20pathway&amp;author=C%20Zhang&amp;author=Q%20Peng&amp;author=Y%20Tang&amp;author=C%20Wang&amp;author=S%20Wang&amp;volume=150&amp;issue=3&amp;publication_year=2024&amp;pages=168-168&amp;pmid=38546908&amp;doi=10.1007/s00432-024-05625-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>Singh G, Famta P, Shah S, Vambhurkar G, Pandey G, Kumar R, Kumar P, Mourya A, Madan J, Srivastava S, Khatri DK. Nanoparticle-enhanced delivery of resveratrol for targeted therapy of glioblastoma: Modulating the Akt/GSK-3β/NF-kB pathway in C6 glioma cells. Brain Res. 2025;1848:149411–149411. doi: 10.1016/j.brainres.2024.149411.</cite> [<a href="https://doi.org/10.1016/j.brainres.2024.149411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39716595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Res&amp;title=Nanoparticle-enhanced%20delivery%20of%20resveratrol%20for%20targeted%20therapy%20of%20glioblastoma:%20Modulating%20the%20Akt/GSK-3%CE%B2/NF-kB%20pathway%20in%20C6%20glioma%20cells&amp;author=G%20Singh&amp;author=P%20Famta&amp;author=S%20Shah&amp;author=G%20Vambhurkar&amp;author=G%20Pandey&amp;volume=1848&amp;publication_year=2025&amp;pages=149411-149411&amp;pmid=39716595&amp;doi=10.1016/j.brainres.2024.149411&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>Giordano F, Montalto FI, Panno ML, Andò S, De Amicis F. A Notch inhibitor plus Resveratrol induced blockade of autophagy drives glioblastoma cell death by promoting a switch to apoptosis. Am J Cancer Res. 2021;11(12):5933–5950. <a href="https://pubmed.ncbi.nlm.nih.gov/35018234/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35018234/</a></cite> [<a href="/articles/PMC8727809/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35018234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Cancer%20Res&amp;title=A%20Notch%20inhibitor%20plus%20Resveratrol%20induced%20blockade%20of%20autophagy%20drives%20glioblastoma%20cell%20death%20by%20promoting%20a%20switch%20to%20apoptosis&amp;author=F%20Giordano&amp;author=FI%20Montalto&amp;author=ML%20Panno&amp;author=S%20And%C3%B2&amp;author=F%20De%20Amicis&amp;volume=11&amp;issue=12&amp;publication_year=2021&amp;pages=5933-5950&amp;pmid=35018234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>Aghababaei F, Nejati M, Karami H, Darvish M, Mirzaei H. The combination of 5-FU and resveratrol can suppress the growth of glioblastoma cells through downregulation of TRPM2 and β-catenin. J Mol Neurosci. 2024;74(1):7–7. doi: 10.1007/s12031-023-02174-3.</cite> [<a href="https://doi.org/10.1007/s12031-023-02174-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38193979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Mol%20Neurosci&amp;title=The%20combination%20of%205-FU%20and%20resveratrol%20can%20suppress%20the%20growth%20of%20glioblastoma%20cells%20through%20downregulation%20of%20TRPM2%20and%20%CE%B2-catenin&amp;author=F%20Aghababaei&amp;author=M%20Nejati&amp;author=H%20Karami&amp;author=M%20Darvish&amp;author=H%20Mirzaei&amp;volume=74&amp;issue=1&amp;publication_year=2024&amp;pages=7-7&amp;pmid=38193979&amp;doi=10.1007/s12031-023-02174-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. J Neurosurg. 2017;126(5):1448–1460. doi: 10.3171/2016.1.JNS152077.</cite> [<a href="https://doi.org/10.3171/2016.1.JNS152077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5237623/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27419830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurosurg&amp;title=Resveratrol%20targeting%20of%20AKT%20and%20p53%20in%20glioblastoma%20and%20glioblastoma%20stem-like%20cells%20to%20suppress%20growth%20and%20infiltration&amp;author=PA%20Clark&amp;author=S%20Bhattacharya&amp;author=A%20Elmayan&amp;author=SR%20Darjatmoko&amp;author=BA%20Thuro&amp;volume=126&amp;issue=5&amp;publication_year=2017&amp;pages=1448-1460&amp;pmid=27419830&amp;doi=10.3171/2016.1.JNS152077&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>Kiskova T, Kubatka P, Büsselberg D, Kassayova M. The plant-derived compound resveratrol in brain cancer: a review. Biomolecules. 2020;10(1):161–161. doi: 10.3390/biom10010161.</cite> [<a href="https://doi.org/10.3390/biom10010161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7023272/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31963897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=The%20plant-derived%20compound%20resveratrol%20in%20brain%20cancer:%20a%20review&amp;author=T%20Kiskova&amp;author=P%20Kubatka&amp;author=D%20B%C3%BCsselberg&amp;author=M%20Kassayova&amp;volume=10&amp;issue=1&amp;publication_year=2020&amp;pages=161-161&amp;pmid=31963897&amp;doi=10.3390/biom10010161&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data will be available upon request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Acta Cirúrgica Brasileira are provided here courtesy of <strong>Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1590/acb405525"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/1678-2674-acb-40-e405525.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (686.9 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12333572/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12333572/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333572%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333572/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12333572/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12333572/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12333572/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12333572/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12333572/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="6SNpmv7Bs9z2LTFXYITYskogaV5UyX0gjBVerBRYSVqPOiSAEQAJr4vfiWCnVUbr">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-d9849939.js"></script>
    
    

    </body>
</html>
